Xiaoying Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiaoying Guo has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Fujing Man
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China
1 shared publicationHao Lv
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China
1 shared publication- Junping Zhang
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine, Tianjin, China
1 shared publication Qi Shi
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China
1 shared publicationWanqin Zhang
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China
1 shared publicationYaping Zhu
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China
1 shared publication
Latest Publications
- 4 January 2022
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 15 (4) , 730-739
Lipid Droplet—a New Target in Ischemic Heart Disease
Lipid droplet (LD) is a kind of subcellular organelle, which originates from the endoplasmic reticulum (ER). LDs can move flexibly between other organelles and store energy in the cells. In recent years, LDs and lipid droplet–associated proteins have attracted added attention at home and abroad, especially in cardiovascular diseases. Cardiovascular diseases, especially ischemic heart disease (IHD), have always been the focus of attention because of their high morbidity and mortality. Atherosclerosis and myocardial remodeling are two important pathologic processes of IHD, and LDs and other organelles are involved in the development of the disease. The interaction between LDs and ER is involved in the formation of foam cells in atherosclerosis. And LDs, mitochondria, and lysosomes also affect the remodeling of cardiomyocytes by affecting ROS production and regulating PI3K/AKT pathways. In this article, we will review the role of LDs in IHD. Graphical abstract
- 4 January 2022
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 15 (4) , 730-739
Lipid Droplet—a New Target in Ischemic Heart Disease
Lipid droplet (LD) is a kind of subcellular organelle, which originates from the endoplasmic reticulum (ER). LDs can move flexibly between other organelles and store energy in the cells. In recent years, LDs and lipid droplet–associated proteins have attracted added attention at home and abroad, especially in cardiovascular diseases. Cardiovascular diseases, especially ischemic heart disease (IHD), have always been the focus of attention because of their high morbidity and mortality. Atherosclerosis and myocardial remodeling are two important pathologic processes of IHD, and LDs and other organelles are involved in the development of the disease. The interaction between LDs and ER is involved in the formation of foam cells in atherosclerosis. And LDs, mitochondria, and lysosomes also affect the remodeling of cardiomyocytes by affecting ROS production and regulating PI3K/AKT pathways. In this article, we will review the role of LDs in IHD. Graphical abstract